Get to know more about the use of Pembrolizumab for treating lung cancer.
Chemo brain is an effects experienced by most cancer patients undergoing chemotherapy. Research suggests new drug to treat these symptoms.
A new study published in the International Journal of Radiation Oncology, Biology and Physics indicates that yoga helps treat side effects for cancer. Patients with prostate cancer may have fewer side effects from radiation therapy when yoga is done twice a week.
A new study has revealed that most cancer cases occur as a result of errors in DNA, which are found to be entirely random. The study has shown that most cases are not due to heredity or environmental factors.
Kisqali is a new pill approved by the United States Health regulators to slow down the spread of cancers cells in the patient's body.
A new study shows that natural vitamin C can specifically target and kill cancer stem cells preventing them from spreading.
A new study focusing on breast cancer in male revealed two proteins that play a significant role in the disease. This recent discovery may help in stepping up with a new treatment for breast cancer in male patients.
Gleevec Pill keeps CML patients alives for decades- even longer than that.
Exercise and psychological treatments have been found to help in combating the common side effects of chemotherapy and cancer-related fatigue.
In the next 20 years, with the aid of gene editing therapy, cancers and all inherited diseases can be finally cured.
Police are starting to investigate the claims that a teenage cancer patient was faking his terminal condition and was just after for the gifts he has been receiving from charities.
Recent studies reveal that there is now a possible way to tell if a man’s prostate cancer will recur or kills him after being treated.
Breast cancer treatments are already proven to be effective in treating tumors. However, recent studies reveal that its severe side effects.
Breast cancer cells are very difficult to treat and investigators found out what protected these tumor cells.
A team of UC Berkeley scientists reprogrammed embryonic stem cells of mice to exhibit development characteristics of zygotes.